SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain Significant Stake in Doximity Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reaffirming their beneficial ownership of 7.3% of Doximity Inc.'s Class A Common Stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson jointly reported beneficial ownership of 9,409,312.45 shares of Doximity Inc.'s Class A Common Stock.
- This ownership represents 7.3% of the total outstanding Class A Common Stock.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.
- FMR LLC holds sole voting power over 9,401,897.80 shares and sole dispositive power over 9,409,312.45 shares.
- Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is also deemed to beneficially own the same shares due to her role and the Johnson family's controlling interest in FMR LLC.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Doximity Inc.
- Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, are identified as entities that beneficially own shares, with Fidelity Management & Research Company LLC owning 5% or greater of the outstanding shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While a Schedule 13G is a factual disclosure, the continued significant holding by a reputable institutional investor like FMR LLC can be seen as a positive signal of confidence in the company, Doximity Inc. There are no negative implications or risks disclosed within the filing itself.
Positives
- The continued significant stake (7.3%) by a major institutional investor like FMR LLC and its leadership, Abigail P. Johnson, can be interpreted as a vote of confidence in Doximity Inc.'s long-term prospects.
- The filing confirms that the shares are held in the ordinary course of business, indicating a passive investment rather than an activist stance that might signal underlying issues.
Future Outlook
Not applicable, as this filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.
Industry Context
This filing highlights the continued significant institutional investment in Doximity Inc., a prominent player in the healthcare technology sector. The sustained stake by FMR LLC, a major asset manager, underscores the ongoing interest of large investment firms in companies leveraging technology to serve the healthcare industry.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence investor perception and potentially market stability.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of filing of Schedule 13G by FMR LLC where Abigail P. Johnson's power of attorney was incorporated by reference. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2025-02-11 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Doximity Inc., FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Class A Common Stock, Institutional Investor, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.